ATARA BIOTHERAPEUTICS, INC. Restricted Cash, Current
ATARA BIOTHERAPEUTICS, INC. (ATRA) had Restricted Cash, Current of $0 as of 2025-12-31, per its 10-K filed 2026-03-16.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:RestrictedCashCurrent · last filed 2026-03-16
- 2025-12-31: Restricted Cash, Current $0.00.
- 2025-09-30: Restricted Cash, Current $0.00.
- 2025-06-30: Restricted Cash, Current $0.00.
- 2025-03-31: Restricted Cash, Current $146.00K.
| Period end | Restricted Cash, Current |
|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-16 |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-12 |
| 2025-06-30 | $0.00 10-Q · filed 2025-08-11 |
| 2025-03-31 | $146.00K 10-Q · filed 2025-05-15 |
| 2024-12-31 | $146.00K 10-K · filed 2026-03-16 |
| 2024-09-30 | $146.00K 10-Q · filed 2024-11-12 |
| 2024-06-30 | $146.00K 10-Q · filed 2024-08-12 |
| 2024-03-31 | $146.00K 10-Q · filed 2024-05-09 |
| 2023-12-31 | $146.00K 10-K · filed 2025-03-07 |
| 2023-09-30 | $146.00K 10-Q · filed 2023-11-01 |
| 2023-06-30 | $146.00K 10-Q · filed 2023-08-08 |
| 2023-03-31 | $146.00K 10-Q · filed 2023-05-08 |
| 2022-12-31 | $146.00K 10-K · filed 2024-03-28 |
| 2022-09-30 | $1.35M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $1.35M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $146.00K 10-Q · filed 2022-05-05 |
| 2021-12-31 | $194.00K 10-K · filed 2023-02-08 |
| 2021-09-30 | $194.00K 10-Q · filed 2021-11-04 |
| 2021-06-30 | $194.00K 10-Q · filed 2021-08-09 |
| 2021-03-31 | $194.00K 10-Q · filed 2021-05-04 |
| 2020-12-31 | $194.00K 10-K · filed 2022-02-28 |
| 2020-09-30 | $194.00K 10-Q · filed 2020-11-09 |
| 2020-06-30 | $194.00K 10-Q · filed 2020-08-05 |
| 2020-03-31 | $194.00K 10-Q · filed 2020-05-06 |
| 2019-12-31 | $194.00K 10-K · filed 2021-03-01 |
| 2019-09-30 | $194.00K 10-Q · filed 2019-11-07 |
| 2019-06-30 | $194.00K 10-Q · filed 2019-08-08 |
| 2019-03-31 | $194.00K 10-Q · filed 2019-05-09 |
| 2018-12-31 | $194.00K 10-K · filed 2020-02-27 |
| 2017-12-31 | $194.00K 10-K · filed 2019-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |